Amarin reported $18.8M in Trade Creditors for its fiscal quarter ending in June of 2026.





Trade Creditors Change Date
AbbVie USD 3.59B 28.65B Dec/2025
Alnylam Pharmaceuticals USD 108.02M 18.61M Jun/2026
Amarin USD 18.8M 29.36M Jun/2026
AstraZeneca USD 22.89B 388M Jun/2026
BioCryst Pharmaceuticals USD 11.46M 501K Jun/2026
DBV Technologies USD 39.5M 1.44M Mar/2026
GlaxoSmithKline GBP 14.34B 7M Jun/2026
Halozyme Therapeutics USD 23.61M 9.51M Jun/2026
Heron Therapeutics USD 11.64M 2.67M Jun/2026
Ionis Pharmaceuticals USD 47.7M 21.67M Jun/2026
Nektar Therapeutics USD 10.03M 744K Mar/2026
Neurocrine Biosciences USD 691.3M 145.8M Mar/2026
Novartis USD 4.26B 64M Jun/2026